Browsing Category
Pharma Industry News
4734 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Dupixent keeps winning trials—but can it survive the real battle with payers?
Explore how payer dynamics and pricing strategy may pose the biggest challenge for Dupixent’s growth, beyond clinical trials or biologic competitors.
Radiopharm Theranostics (ASX: RAD) begins third cohort in PD-L1 trial—could 177Lu-RAD204 be a game-changer?
Radiopharm Theranostics moves to third cohort in PD-L1 trial with 90mCi dose approval. Explore what this means for its radiopharmaceutical ambitions.
Vyepti and Rexulti power Lundbeck (CPH: LUN) to raise 2025 guidance after 22% adjusted EBITDA surge
Lundbeck lifts 2025 guidance as Vyepti and Rexulti drive 22% EBITDA growth. Explore the neuroscience-focused strategy powering its latest earnings surge.
SOPHiA GENETICS integrates AI analytics with Complete Genomics sequencing to accelerate precision medicine adoption
Find out how SOPHiA GENETICS and Complete Genomics are revolutionizing cancer diagnostics through an AI-integrated sequencing platform driving precision medicine.
Is Oracle building the next operating system for oncology? Inside its AI push with Ci4CC
Oracle and Ci4CC join forces to drive AI and data science innovation in oncology. Find out how this partnership could reshape cancer care infrastructure.
Salarius Pharmaceuticals raises $7m in underwritten offering to fund merger and R&D pipeline
Find out how Salarius Pharmaceuticals is raising $7 million through a structured equity offering as it funds a merger and next-generation biotech pipeline.
Can Allurion Technologies reset investor confidence with FDA momentum and a debt-free strategy?
Allurion Technologies aims to bounce back with FDA milestones, a debt-free strategy, and new capital. Will this turnaround move the stock in 2025?
Quoin Pharmaceuticals (NASDAQ: QNRX) spikes over 50% after rapamycin breakthrough in rare disease program
Quoin Pharmaceuticals (NASDAQ: QNRX) stock surged over 50% after achieving key rapamycin delivery targets. Find out how this positions its rare disease pipeline.
Can Camurus’ once-monthly semaglutide depot reshape the future of obesity and diabetes treatment?
Camurus reports positive Phase 1b results for CAM2056, a monthly semaglutide depot, showing 9.3% weight loss and strong A1c reduction. Read the full data.
Zydus Lifesciences Q2 profit jumps 38% as US and China approvals sharpen global expansion strategy
Zydus Lifesciences Limited reports strong Q2 FY26 results and secures post-earnings approvals in the United States and China. Read more on investor sentiment and next steps.